Effect of supplementation in treatment of women with polycystic ovary syndrome

Phase 2

• Conditions: Polycystic ovary syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT201601085623N67
• Lead Sponsor: Vice chancellor for research, Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 68

Inclusion Criteria

Patients with PCOS according to Rotterdam criteria
Higher than 5 years of their disease
Aged 18 to 40 years

Exclusion Criteria

Unwillingness to cooperate
Metabolic disorders

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Gene expression of OX-LDL. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR-RT.;Triglycerides. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Enzymatic kit.

Secondary Outcome Measures

Name	Time	Method
DL-cholesterol. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Enzymatic kit.;Gene expression of Lp(a). Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR-RT.;Glutathione. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Spectrophotometry.;Total antioxidant. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Spectrophotometry.;Total cholesterol. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Enzymatic kit.;HDL-cholesterol. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Enzymatic kit.